Evogene : Q1 2024 Consolidated Financial Statements
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...
Stay updated with breaking news from Webcast Details. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF...
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating...
Conference call and webcast: today, May 23, 2024, 9:00 am ET Financial and Business Highlights: Q1 2024 revenue: $4.2M vs. $0.6M in Q1 2023; anticipating continued growth in 2024. Q1 2024 net loss:...
Revenue Grew 12% Year Over Year in the First Quarter and Adjusted EBITDA of S$4 Million Total revenue grew 12% to S$37 million in the first quarter of 2024; Singapore revenue grew 25% Adjusted...
Introduces 3-Year Financial Targets including Minimum 5% Organic Revenue CAGR, Minimum 10% EPS CAGR and Strong Free Cash Flow Generation, as well as Commercial Nuclear Upside...